American Trust’s Bristol-Myers Squibb BMY Stock Holding History

American Trust’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$346K	Buy	+5,713	New	+$333K	0.03%	203
2023 Q3	–	Sell	-7,337	Closed	-$469K	–	298
2023 Q2	$469K	Sell	7,337 -251	-3%	-$16.8K	0.03%	229
2023 Q1	$526K	Buy	7,588 +35	+0.5%	+$2.47K	0.04%	203
2022 Q4	$543K	Sell	7,553 -126	-2%	-$9.5K	0.05%	201
2022 Q3	$546K	Sell	7,679 -230	-3%	-$16.7K	0.05%	181
2022 Q2	$609K	Buy	7,909 +2,880	+57%	+$219K	0.05%	188
2022 Q1	$368K	Buy	+5,029	New	+$338K	0.02%	305

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

American Trust's BMY Position: Q1 2026 in Review

American Trust opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 5,713 shares worth $346K. The stake represents 0.03% of the portfolio and ranks #203 among its holdings. This is a return to the name: American Trust previously reported a position in BMY as recently as Q2 2023.

American Trust first reported a position in BMY in Q1 2022 and has held it in 7 quarters since. The position peaked at $609K in Q2 2022. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

American Trust held 5,713 shares of Bristol-Myers Squibb worth $346K as of Q1 2026.
Bristol-Myers Squibb was a new American Trust position in Q1 2026.
Bristol-Myers Squibb made up 0.03% of American Trust's portfolio in Q1 2026, its #203 holding.
American Trust first reported a position in Bristol-Myers Squibb in Q1 2022 and has held it in 7 quarters since.
American Trust's Bristol-Myers Squibb position peaked at $609K in Q2 2022.
2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on American Trust's 13F filing for Q1 2026, filed 1 May 2026.